Gene: ARHGEF16
Official Full Name: Rho guanine nucleotide exchange factor 16provided by HGNC
Gene Summary: Although the specific function of this protein is not known yet, it is thought to be involved in protein-protein and protein-lipid interactions. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27740 | ARHGEF16 Knockout cell line (HeLa) | Human | ARHGEF16 | 1:3~1:6 | Negative | Online Inquiry |
KO27741 | ARHGEF16 Knockout cell line (HCT 116) | Human | ARHGEF16 | 1:2~1:4 | Negative | Online Inquiry |
KO27742 | ARHGEF16 Knockout cell line (HEK293) | Human | ARHGEF16 | 1:3~1:6 | Negative | Online Inquiry |
KO27743 | ARHGEF16 Knockout cell line (A549) | Human | ARHGEF16 | 1:3~1:4 | Negative | Online Inquiry |
ARHGEF16 Gene Knockout Cell Lines represent a sophisticated tool for researchers seeking to explore the biological functions and regulatory networks associated with the ARHGEF16 gene. This product comprises a series of engineered cell lines in which the ARHGEF16 gene has been precisely knocked out using CRISPR/Cas9 technology, enabling the in-depth study of its role in cellular processes and disease states.
The key function of these cell lines is to provide a controlled environment for observing the phenotypic consequences of ARHGEF16 gene ablation. The ARHGEF16 protein is implicated in critical cellular signaling pathways, including those regulating cytoskeletal dynamics and cell migration. By utilizing these knockout cell lines, researchers can investigate how the absence of ARHGEF16 affects cellular behavior, signal transduction pathways, and interactions with other molecular players, thus elucidating its role in conditions such as cancer and neurological disorders.
The scientific importance of ARHGEF16 Gene Knockout Cell Lines extends into both basic and applied research domains. They are invaluable for functional genomics studies, drug discovery, and therapeutic development in clinical settings. Additionally, they offer a platform for screening potential therapeutic compounds targeting the pathways modulated by ARHGEF16, bolstering translational research efforts.
Compared to traditional methods of gene manipulation, the precision and efficiency of CRISPR/Cas9 technology for creating ARHGEF16 knockout models represent a significant advancement. These cell lines reduce the time and labor typically associated with generating stable knockout lines and provide reliable and reproducible results, setting them apart from alternative knockout strategies.
For researchers and clinicians, ARHGEF16 Gene Knockout Cell Lines offer a reliable and effective resource for probing significant biological questions and developing novel therapeutics. By incorporating this product into their research pipeline, users can accelerate their findings and contribute to the growing body of knowledge within the field.
As a leader in the development of cutting-edge biological products, our company is committed to equipping scientists with robust tools that facilitate discovery and innovation in molecular biology and genetics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.